Shah Kashmira, Tom Blake J, Huang Christopher, Fischer Paul, Koo Gloria C
Merck Research Laboratories, 80W-107, PO Box 2000, Rahway, NJ 07065, USA.
Cell Immunol. 2003 Feb;221(2):100-6. doi: 10.1016/s0008-8749(03)00063-7.
The voltage gated potassium channel (Kv1.3) has been shown to play a role in immune responsiveness. Blockade of the channel led to diminution of T cell activation and delayed type hypersensitivity. Previous in vitro studies of the blockade were focused on T cell activation and proliferation. In this study we examined other T and monocytic cell mediated events to glean the extent of the immunosuppressive effects of a Kv1.3 specific inhibitor, Margatoxin (MgTX). We found that MgTX inhibited the intracellular production of Th-1 as well as Th-2 cytokines. MgTX can also inhibit IL-2 production and proliferation of T cells upon stimulation with anti-CD3 and VCAM-1. Furthermore, a redirected cytolytic activity was also inhibited by MgTX. However, MgTX did not inhibit generation of CTL to EBV transformed lymphoma cells or antibody-dependent cellular cytolysis mediated by monocytes. It appears that a Kv1.3 blockade does not affect all immune responses, particularly those of innate immunity.
电压门控钾通道(Kv1.3)已被证明在免疫反应中发挥作用。该通道的阻断导致T细胞活化减弱和迟发型超敏反应延迟。先前对该阻断的体外研究主要集中在T细胞活化和增殖上。在本研究中,我们检测了其他T细胞和单核细胞介导的事件,以了解Kv1.3特异性抑制剂玛格毒素(MgTX)的免疫抑制作用程度。我们发现MgTX抑制Th-1以及Th-2细胞因子的细胞内产生。MgTX还可以抑制抗CD3和VCAM-1刺激后T细胞的IL-2产生和增殖。此外,MgTX也抑制重定向细胞溶解活性。然而,MgTX不抑制针对EBV转化淋巴瘤细胞的CTL生成或单核细胞介导的抗体依赖性细胞溶解。看来Kv1.3阻断并不影响所有免疫反应,特别是先天免疫反应。